Genesco CFO granted 11,424 restricted shares

Collins Jonathan M. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 08/04/2026 - 04:32 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Collins Jonathan M. reported acquisition or exercise transactions in this Form 4 filing.

GENESCO INC SVP Finance and CFO Jonathan M. Collins received a grant of 11,424 shares of restricted common stock at $0.00 per share under the Fourth Amended and Restated 2020 Equity Incentive Plan. The award vests in three equal tranches on August 3, 2027, April 4, 2028, and April 4, 2029, and Collins holds 11,424 shares directly after this grant.

Insider Trade Summary

Grant/Award: 11,424 shares

Grant/Award 1 txn

Insider Collins Jonathan M.

Role SVP Finance and CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	11,424	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,424 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan. The first one-third tranche of the award will vest on August 3, 2027. The second and third tranches of the restricted stock award will vest on April 4, 2028 and April 4, 2029, respectively.

Key Figures

Restricted stock granted: 11,424 shares Grant price per share: $0.00 Shares held after grant: 11,424 shares +3 more

6 metrics

Restricted stock granted 11,424 shares Grant of restricted common stock to SVP Finance and CFO on 2026-08-03

Grant price per share $0.00 Restricted shares granted at no cash purchase price to the executive

Shares held after grant 11,424 shares Direct holdings of Genesco common stock following the reported grant

First vesting date August 3, 2027 First one-third of the restricted stock award scheduled to vest

Second vesting date April 4, 2028 Second one-third tranche of the restricted stock award scheduled to vest

Third vesting date April 4, 2029 Final one-third tranche of the restricted stock award scheduled to vest

Key Terms

restricted stock, Fourth Amended and Restated 2020 Equity Incentive Plan, tranche, vest

4 terms

restricted stock financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Fourth Amended and Restated 2020 Equity Incentive Plan financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan"

tranche financial

"The first one-third tranche of the award will vest on August 3, 2027"

A tranche is one slice of a larger financing or investment that is released, sold, or paid out in separate parts rather than all at once. Investors care because each slice can carry different risk, return and timing—like buying pieces of a cake where some slices are richer or come later—so the specific tranche you hold affects when you get paid and how much you might gain or lose.

vest financial

"The first one-third tranche of the award will vest on August 3, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genesco (GCO) report for Jonathan M. Collins?

Genesco reported that SVP Finance and CFO Jonathan M. Collins received 11,424 shares of restricted common stock at $0.00 per share. The grant was made under the Fourth Amended and Restated 2020 Equity Incentive Plan as part of his equity-based compensation.

How many Genesco (GCO) shares does Jonathan M. Collins hold after this Form 4 grant?

After the reported grant, Jonathan M. Collins directly holds 11,424 shares of Genesco common stock. These shares consist of the newly awarded restricted stock, which remains subject to a multi-year vesting schedule extending through April 4, 2029.

What is the vesting schedule for Jonathan M. Collins’s Genesco (GCO) restricted stock award?

The 11,424-share restricted stock award vests in three equal tranches. One-third vests on August 3, 2027, the second third on April 4, 2028, and the final third on April 4, 2029, subject to the plan’s terms.

Under which plan was Jonathan M. Collins’s Genesco (GCO) restricted stock granted?

The restricted stock was granted under Genesco’s Fourth Amended and Restated 2020 Equity Incentive Plan. This plan provides equity-based compensation, such as restricted stock, to executives and other participants to align their interests with shareholders over time.

Did Jonathan M. Collins pay a purchase price for his new Genesco (GCO) restricted shares?

No cash purchase price was paid; the 11,424 restricted shares were granted at $0.00 per share. This reflects a compensation award of stock rather than an open-market purchase of Genesco common shares by the executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collins Jonathan M.

(Last) (First) (Middle)

C/O GENESCO INC.

535 MARRIOTT DRIVE

(Street)

NASHVILLE TENNESSEE 37214

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP Finance and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/03/2026		A		11,424(1)	A	$0.00	11,424	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan. The first one-third tranche of the award will vest on August 3, 2027. The second and third tranches of the restricted stock award will vest on April 4, 2028 and April 4, 2029, respectively.

	Scott E. Becker, Attorney-in-Fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)